ArticleScientific reports2026
A hybrid pipeline for carotid artery segmentation using YOLOv11n and contour models.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carotid artery segmentation is critical for determining the degree of vascular disease, and for recommending treatment options. Early detection of carotid atherosclerosis is critical for preventing stroke. Stroke-related brain damage can cause deficits in speech or vision, and large strokes can be fatal. However, automatic segmentation of the carotid artery lumen remains difficult due to the low quality of US images, and the existence of stenosis, jugular veins, and abnormalities in carotid images. This article presents a hybrid pipeline for segmenting both carotid transverse and longitudinal lumens without any user interaction. This hybrid pipeline starts with automatically localizing the carotid artery lumen in the transverse and longitudinal sections via YOLOv11n. Then, a multistage preprocessing framework was applied to the transverse section before its lumen was segmented by the active contour. For the longitudinal section, an automated padded mask was generated to guarantee reliable initialization for Chan-Vese level-set evolution. A paired t test validated the relevance of the proposed modules (p < 0.0001). The proposed multiphase segmentation pipeline achieved a Dice index and accuracy of 94.9% and 97.7%, respectively, for the longitudinal section and 90.8% and 99.6%, respectively, for the transverse section. A comprehensive ablation analysis has shown that numerical stability depends on the YOLOv11n localization phase. The system attained near real-time inference for the carotid transverse section (< 1 s) despite being evaluated on low-end hardware, demonstrating its computational efficiency and promise for clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.